| 51 |
24292054 | Prediction of in vivo carbamazepine 10,11-epoxidation from in vitro metabolic studies with human liver microsomes: importance of its sigmoidal kinetics. | 2013 |
1 |
| 52 |
24382036 | [Pulmonary embolism due to interaction between rivaroxaban and carbamazepine]. | 2013 |
1 |
| 53 |
21996064 | Histone deacetylase 1 is required for Carbamazepine-induced CYP3A4 expression. | 2012 Jan 25 |
7 |
| 54 |
22197672 | Prediction of sites of metabolism in a substrate molecule, instanced by carbamazepine oxidation by CYP3A4. | 2012 Jan 15 |
2 |
| 55 |
21190921 | Therapeutic effects of ciprofloxacin on the pharmacokinetics of carbamazepine in healthy adult male volunteers. | 2011 Jan |
2 |
| 56 |
21294720 | Cellular localization and functional significance of CYP3A4 in the human epileptic brain. | 2011 Mar |
2 |
| 57 |
21441468 | Simulation of clinical drug-drug interactions from hepatocyte CYP3A4 induction data and its potential utility in trial designs. | 2011 Jul |
1 |
| 58 |
21832258 | Luciferin IPA-based higher throughput human hepatocyte screening assays for CYP3A4 inhibition and induction. | 2011 Sep |
1 |
| 59 |
21992114 | The structural basis for homotropic and heterotropic cooperativity of midazolam metabolism by human cytochrome P450 3A4. | 2011 Dec 20 |
2 |
| 60 |
20369030 | Clinical pharmacokinetic interactions between antiepileptic drugs and hormonal contraceptives. | 2010 Mar 1 |
1 |
| 61 |
20699409 | A 96-well plate assay for CYP4503A induction using cryopreserved human hepatocytes. | 2010 Nov |
1 |
| 62 |
20847137 | CYP3A4*16 and CYP3A4*18 alleles found in East Asians exhibit differential catalytic activities for seven CYP3A4 substrate drugs. | 2010 Dec |
4 |
| 63 |
19006545 | 4beta-hydroxycholesterol as an endogenous marker for CYP3A4/5 activity. Stability and half-life of elimination after induction with rifampicin. | 2009 Jan |
1 |
| 64 |
19182847 | Carbamazepine and falsely positive screening tests for Cushing's syndrome. | 2009 Jan 23 |
1 |
| 65 |
19255940 | Functional characterization of CYP3A4.16: catalytic activities toward midazolam and carbamazepine. | 2009 Feb |
1 |
| 66 |
19451401 | Evaluation of luciferin-isopropyl acetal as a CYP3A4 substrate for human hepatocytes: effects of organic solvents, cytochrome P450 (P450) inhibitors, and P450 inducers. | 2009 Aug |
1 |
| 67 |
19744012 | Effect of CYP3A5*3 genotype on serum carbamazepine concentrations at steady-state in Korean epileptic patients. | 2009 Oct |
2 |
| 68 |
17971810 | Pharmacodynamics of carbamazepine-mediated induction of CYP3A4, CYP1A2, and Pgp as assessed by probe substrates midazolam, caffeine, and digoxin. | 2008 Jul |
2 |
| 69 |
18096676 | CYP3A4-Mediated carbamazepine (CBZ) metabolism: formation of a covalent CBZ-CYP3A4 adduct and alteration of the enzyme kinetic profile. | 2008 Mar |
12 |
| 70 |
18279471 | Time course of the increase in 4beta-hydroxycholesterol concentration during carbamazepine treatment of paediatric patients with epilepsy. | 2008 May |
2 |
| 71 |
18372180 | An epoxidation mechanism of carbamazepine by CYP3A4. | 2008 May 1 |
5 |
| 72 |
18420779 | Comparative analysis of CYP3A heteroactivation by steroid hormones and flavonoids in different in vitro systems and potential in vivo implications. | 2008 Jul |
1 |
| 73 |
18463198 | Pathways of carbamazepine bioactivation in vitro. III. The role of human cytochrome P450 enzymes in the formation of 2,3-dihydroxycarbamazepine. | 2008 Aug |
4 |
| 74 |
18781906 | Influence of enzyme-inducing antiepileptic drugs on trough level of imatinib in glioblastoma patients. | 2008 Sep |
1 |
| 75 |
18783297 | General framework for the prediction of oral drug interactions caused by CYP3A4 induction from in vivo information. | 2008 |
2 |
| 76 |
17346248 | A comparative pharmacokinetic study in healthy volunteers of the effect of carbamazepine and oxcarbazepine on cyp3a4. | 2007 Mar |
4 |
| 77 |
17374625 | Does metronidazole interact with CYP3A substrates by inhibiting their metabolism through this metabolic pathway? Or should other mechanisms be considered? | 2007 Apr |
1 |
| 78 |
17502775 | Pharmacokinetics of aripiprazole and concomitant carbamazepine. | 2007 Jun |
1 |
| 79 |
17541885 | Effects of comedication on the serum levels of aripiprazole: evidence from a routine therapeutic drug monitoring service. | 2007 May |
1 |
| 80 |
18033049 | [Carbamazepine and clarithromycin: a clinically relevant drug interaction]. | 2007 Nov |
1 |
| 81 |
16390352 | Effects of cytochrome P450 3A modulators ketoconazole and carbamazepine on quetiapine pharmacokinetics. | 2006 Jan |
1 |
| 82 |
16600452 | Effect of carbamazepine on the single oral dose pharmacokinetics of perospirone and its active metabolite. | 2006 Sep 30 |
1 |
| 83 |
16720703 | Carbamazepine toxicity induced by lopinavir/ritonavir and nelfinavir. | 2006 Jun |
1 |
| 84 |
17190925 | Optimizing therapy of seizures in women who use oral contraceptives. | 2006 Dec 26 |
1 |
| 85 |
15572649 | Predictive models of CYP3A4 Heteroactivation: in vitro-in vivo scaling and pharmacophore modeling. | 2005 Mar |
2 |
| 86 |
15673597 | Effects of pomegranate juice on human cytochrome p450 3A (CYP3A) and carbamazepine pharmacokinetics in rats. | 2005 May |
3 |
| 87 |
15708356 | Novel pathways of bile acid metabolism involving CYP3A4. | 2005 Feb 21 |
1 |
| 88 |
15747502 | Autoantibodies against CYP2D6 and other drug-metabolizing enzymes in autoimmune hepatitis type 2. | 2005 |
1 |
| 89 |
15829439 | Study of urinary 6 beta-hydroxycortisol/cortisol ratio in spot urine sample as a biomarker of 3A4 enzyme activity in healthy and epileptic subjects of Egyptian population. | 2005 Jun |
2 |
| 90 |
16135660 | Pathways of carbamazepine bioactivation in vitro: II. The role of human cytochrome P450 enzymes in the formation of 2-hydroxyiminostilbene. | 2005 Dec |
2 |
| 91 |
16318439 | Clinical use of carbamazepine for bipolar disorders. | 2005 Dec |
1 |
| 92 |
15024831 | [A case of polymyalgia rheumatica with improved steroid-responsibility after discontinuing carbamazepine]. | 2004 Jan |
1 |
| 93 |
15298747 | Urinary 6beta-hydroxycortisol/17-hydroxycorticosteroids ratio as a measure of hepatic CYP3A4 capacity after enzyme induction. | 2004 Jul |
1 |
| 94 |
15371980 | Carbamazepine regulates intestinal P-glycoprotein and multidrug resistance protein MRP2 and influences disposition of talinolol in humans. | 2004 Sep |
1 |
| 95 |
15383492 | Evidence of significant contribution from CYP3A5 to hepatic drug metabolism. | 2004 Dec |
1 |
| 96 |
15519127 | Carbamazepine pharmacokinetics are not affected by zonisamide: in vitro mechanistic study and in vivo clinical study in epileptic patients. | 2004 Nov |
2 |
| 97 |
12606595 | In vivo CYP3A4 heteroactivation is a possible mechanism for the drug interaction between felbamate and carbamazepine. | 2003 Jun |
8 |
| 98 |
12642469 | CYP3A4 and CYP3A7-mediated carbamazepine 10,11-epoxidation are activated by differential endogenous steroids. | 2003 Apr |
2 |
| 99 |
12673034 | Induction of CYP3As in HepG2 cells by several drugs. Association between induction of CYP3A4 and expression of glucocorticoid receptor. | 2003 Apr |
3 |
| 100 |
14512885 | Sex is a major determinant of CYP3A4 expression in human liver. | 2003 Oct |
1 |